Reslizumab
From Infogalactic: the planetary knowledge core
Lua error in Module:Infobox at line 166: malformed pattern (missing ']'). Reslizumab (trade name Cinquil) is a humanized monoclonal antibody intended for the treatment of eosinophil-meditated inflammations of the airways, skin and gastrointestinal tract.[1] The drug is undergoing phase II/III clinical trials.[2]
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references> tag; parameter "group" is allowed only.
<references />, or <references group="..." /><templatestyles src="Asbox/styles.css"></templatestyles>
 |
This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. |
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |
Categories:
- Pages with reference errors
- Drugs that are a monoclonal antibody
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemicals that do not have a ChemSpider ID assigned
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Monoclonal antibodies
- Monoclonal antibody stubs
- Respiratory system drug stubs
